biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Last day for tax-loss selling is today!

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Dec 28, 2022 5:06pm

106 Views

Post# 35194374

RE:RE:RE:RE:RE:Last day for tax-loss selling is today!

Yes. People, some, a few, many, are interested in what this nut job has to say, Craig.

I signed up a week ago. In a few days I will have twice as many thumbs up as you have earned in over 12 years.

Please, people, shove some thumbs up his way.

Sorry.

I have to go get ready.

We're expecting your afternoon shriek to begin any moment now.

jd

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment